“The mechanism that PPMOs use to kill bacteria is revolutionary”
Researchers at Oregon State University and other institutions today announced the successful use of a new type of antibacterial agent called a PPMO, which appears to function as well or better than an antibiotic, but may be more precise and also solve problems with antibiotic resistance.
In animal studies, one form of PPMO showed significant control of two strains of Acinetobacter, a group of bacteria of global concern that has caused significant mortality among military personnel serving in Middle East combat.
The new PPMOs offer a fundamentally different attack on bacterial infection, researchers say.
They specifically target the underlying genes of a bacterium, whereas conventional antibiotics just disrupt its cellular function and often have broader, unwanted impacts. As they are further developed, PPMOs should offer a completely different and more precise approach to managing bacterial infection, or conceptually almost any disease that has an underlying genetic component.
The findings were published today in the Journal of Infectious Diseases, by researchers from OSU, the University of Texas Southwestern Medical Center, and Sarepta, Inc., a Corvallis, Ore., firm.
“The mechanism that PPMOs use to kill bacteria is revolutionary,” said Bruce Geller, a professor of microbiology in the OSU College of Science and lead author on the study. “They can be synthesized to target almost any gene, and in that way avoid the development of antibiotic resistance and the negative impacts sometimes associated with broad-spectrum antibiotics.
“Molecular medicine,” Geller said, “is the way of the future.”
PPMO stands for a peptide-conjugated phosphorodiamidate morpholino oligomer – a synthetic analog of DNA or RNA that has the ability to silence the expression of specific genes. Compared to conventional antibiotics, which are often found in nature, PPMOs are completely synthesized in the laboratory with a specific genetic target in mind.
In animal laboratory tests against A. baumannii, one of the most dangerous Acinetobacter strains, PPMOs were far more powerful than some conventional antibiotics like ampicillin, and comparable to the strongest antibiotics available today. They were also effective in cases where the bacteria were resistant to antibiotics.
PPMOs have not yet been tested in humans. However, their basic chemical structure, the PMO, has been extensively tested in humans and found safe. Although the addition of the peptide to the PPMO poses an uncertain risk of toxicity, the potency of PPMOs reduces the risk while greatly improving delivery of the PMOs into bacterial cells, Geller said.
Go deeper with Bing News on:
- Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram Presents at Bank of America Napa Healthcare Conference (Transcript)on June 24, 2020 at 3:53 pm
SRPT) Bank of America Napa Healthcare Conference June 24, 2020 12:30 PM ET Company Participants Doug Ingram - President & ...
- ‘Cobra Kai’ Moves to Netflix Ahead of Season 3 Premiereon June 22, 2020 at 9:00 am
Cobra Kai” is leaving YouTube Premium for a new home at Netflix ahead of the show’s third season, Variety has learned. Under the terms of the deal, the first two seasons of the series will be ...
- Farmington residents asked to reduce outdoor wateringon June 22, 2020 at 8:39 am
Connecticut Water customers in Farmington are being asked to cut back their use of lawn sprinklers for the next 24 hours. A mechanical issue caused the temporary ...
- Sarepta (SRPT) Q2 Loss Widens Y/Y, Golodirsen Nears Approvalon June 16, 2020 at 5:00 pm
The increase was primarily due to the ramp-up of manufacturing activities for micro-dystrophin program and progress of clinical development related to gene therapies, the PPMO platform and casimersen.
- Hybrid Drivetrain Market Trends- Industry Analysis, Share, Growth, Product, Top Key Players and Forecast 2026on June 8, 2020 at 10:17 pm
Selbyville, Delaware this Global Hybrid Drivetrain report studies the industry based on one or more segments covering key players, types, applications, products, technology, end-users, and regions for ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Chiki Diki Launches New Antimicrobial Clothing Line Offering Washable, Reusable, and Breathable Protection from Harmful Contagions Like COVID-19on June 29, 2020 at 10:14 am
Chiki Diki, an innovative antimicrobial protective clothing company, is pleased to announce its new line of fashionable protective gear and accessories featuring ...
- Spandex adds antimicrobial film to rangeon June 29, 2020 at 6:48 am
The 80mic clear film uses zinc pyrithione as the antimicrobial agent. This is encapsulated in the film to provide protection over an extended period. Spandex said that it would offer “over 99.99% ...
- Podcast Examines Pre-Exposure Prophylaxis for COVID-19 Diseaseon June 28, 2020 at 5:00 pm
Borrowing from successful HIV/AIDS prophylaxis, a TrialSiteNews podcast suggests rethinking the use of a controversial FDA-approved medication to avoid severe COVID-19 ...
- Global Antimicrobial Therapeutics Market 2020-2024 | Evolving Opportunities with AbbVie Inc. and CSL Ltd. | Technavioon June 26, 2020 at 4:00 pm
The global antimicrobial therapeutics market size is expected to grow by USD 42.30 million as per Technavio. This marks a significant market slow growth compared to the 2019 growth estimates due to ...
- Nanomaterials used as broad-spectrum antimicrobial agents for first timeon June 23, 2020 at 4:19 am
In a significant breakthrough in the battle against antibiotic resistance, a research team from the Indian Institute of Science (IISc) has synthesized a nanomaterial that mimics an enzyme and can ...